Here are six observations:
1. The market should grow at a compound annual growth rate of 4.5 percent throughout the five-year period.
2. The spine surgery segment accounts for the largest market share and will likely reach $10.8 billion by 2021, growing at a CAGR of 3.5 percent.
3. The neurostimulation devices segment will see the most rapid growth at a 6.9 percent CAGR, reaching $5 billion in 2021.
4. In 2015, spinal fusion products accounted for 72 percent of global spine sales volumes; while spinal surgery biologic products captured 17 percent; and total spinal disc replacement devices accounted for 3 percent.
5. Within the neurostimulation sphere, spinal cord stimulation products are dominating, accounting for the 50 percent of the market.
6. The United States leads the spinal intervention market, capturing a 71 percent share of spinal surgery products sales and 69 percent of neurostimulation products sales, in 2015.
More articles on devices:
Medovex, AlfaMed, & more: 4 recent device company partnerships
Reprocessed medical devices market gaining traction — 4 observations
4 things to know about Intelligent Implant Systems
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
